Effect of Helicobacter Pylori Eradication According to the IL-8-251 Polymorphism in Koreans

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2012 Oct 24

PMID 23091318

Citations 5

Authors

Hae Yeon Kang

Sang Gyun Kim

Mi Kyung Lee

Joo Sung Kim

Hyun Chae Jung

In Sung Song

Affiliations

Soon will be listed here.

Abstract

Previous studies suggested that polymorphisms of proinflammatory cytokine genes are important host genetic factors in Helicobacter pylori infection. The present study evaluated whether IL-8-251 polymorphism affected H. pylori eradication rate and to investigate the effect of H. pylori eradication on angiogenesis and the inflammatory process according to the IL-8-251 polymorphism. A total of 250 H. pylori-positive patients treated by endoscopic resection of the gastric neoplasm were classified into 3 groups (134 H. pylori-eradicated group, 19 H. pylori-eradication failure group, and 97 H. pylori-infected group). H. pylori status, histology, and angiogenic factor levels were evaluated at baseline, 6 months, and 18 months. H. pylori eradication rate was 92.9% in AA genotype, 85.7% in AT genotype and 88.4% in TT genotype (P value = 0.731). Elevated IL-8 and matrix metalloproteinase-9 concentrations in H. pylori-infected gastric mucosa were reversible by successful eradication of H. pylori, independent of the IL-8-251 polymorphism. It is suggested that elevated IL-8 and MMP-9 concentrations in H. pylori-infected gastric mucosa are altered significantly after successful eradication and these conditions continue for 18 months. However, IL-8-251 polymorphism does not affect H. pylori eradication rate and the sequential changes of related angiogenic factors after H. pylori eradication in Koreans.

Citing Articles

Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.

Park J, Kim M, Choi I, Kim J, Kim J, Lee K PLoS One. 2022; 17(10):e0276497.

PMID: 36269747 PMC: 9586384. DOI: 10.1371/journal.pone.0276497.

The Influence of Gene Polymorphisms on Infection and Triple Treatment Response Among Jordanian Population.

Shakhatreh M, Khabour O, Alzoubi K, Banihani M, Abu-Siniyeh A, Bashir N Appl Clin Genet. 2020; 13:139-145.

PMID: 32669867 PMC: 7337447. DOI: 10.2147/TACG.S253778.

Proinflammatory biomarkers' level and functional genetic polymorphisms in periprosthetic joint infection.

Erdemli B, Ozbek E, Basarir K, Karahan Z, Ocal D, Biriken D Acta Orthop Traumatol Turc. 2018; 52(2):143-147.

PMID: 29305046 PMC: 6136306. DOI: 10.1016/j.aott.2017.11.002.

Clinicopathological features and surgical safety of gastric cancer in elderly patients.

Lim J, Lee D, Shin C, Kim N, Park Y, Jung H J Korean Med Sci. 2014; 29(12):1639-45.

PMID: 25469063 PMC: 4248584. DOI: 10.3346/jkms.2014.29.12.1639.

Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?.

Gong E, Yun S, Jung H, Lim H, Choi K, Ahn J J Korean Med Sci. 2014; 29(5):704-13.

PMID: 24851029 PMC: 4024949. DOI: 10.3346/jkms.2014.29.5.704.

References

Song J, Kim S, Jung S, Lee M, Jung H, Song I . The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. Cytokine. 2010; 51(2):158-65. DOI: 10.1016/j.cyto.2010.05.001. View

Zhang Q, Dawodu J, Husain A, Etolhi G, Gemmell C, Russell R . Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci (Lond). 1997; 92(1):69-73. DOI: 10.1042/cs0920069. View

Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H . Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol. 1998; 152(1):93-100. PMC: 1858127. View

Wong B, Lam S, Wong W, Chen J, Zheng T, Feng R . Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291(2):187-94. DOI: 10.1001/jama.291.2.187. View

Craig P, Territo M, KARNES W, Walsh J . Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut. 1992; 33(8):1020-3. PMC: 1379434. DOI: 10.1136/gut.33.8.1020. View

Sung J, Lin S, Ching J, Zhou L, To K, Wang R . Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology. 2000; 119(1):7-14. DOI: 10.1053/gast.2000.8550. View

Mera R, Fontham E, Bravo L, Bravo J, Piazuelo M, Camargo M . Long term follow up of patients treated for Helicobacter pylori infection. Gut. 2005; 54(11):1536-40. PMC: 1462952. DOI: 10.1136/gut.2005.072009. View

Lu W, Pan K, Zhang L, Lin D, Miao X, You W . Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis. 2004; 26(3):631-6. DOI: 10.1093/carcin/bgh349. View

Leung W, Lin S, Ching J, To K, Ng E, Chan F . Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004; 53(9):1244-9. PMC: 1774213. DOI: 10.1136/gut.2003.034629. View

10.

Figueiredo C, Machado J, Pharoah P, Seruca R, Sousa S, Carvalho R . Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002; 94(22):1680-7. DOI: 10.1093/jnci/94.22.1680. View

11.

Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I . Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005; 37(10):990-3. DOI: 10.1055/s-2005-870198. View

12.

Correa P, Houghton J . Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007; 133(2):659-72. DOI: 10.1053/j.gastro.2007.06.026. View

13.

Arima N, Adachi K, Katsube T, Amano K, Ishihara S, Watanabe M . Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol. 1999; 29(1):44-7. DOI: 10.1097/00004836-199907000-00011. View

14.

Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y . Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther. 2002; 16(8):1449-56. DOI: 10.1046/j.1365-2036.2002.01311.x. View

15.

El-Omar E, Rabkin C, Gammon M, Vaughan T, Risch H, Schoenberg J . Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003; 124(5):1193-201. DOI: 10.1016/s0016-5085(03)00157-4. View

16.

Bergin P, Anders E, Sicheng W, Erik J, Jennie A, Hans L . Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter. 2004; 9(3):201-10. DOI: 10.1111/j.1083-4389.2004.00232.x. View

17.

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

18.

Kitadai Y, Sasaki A, Ito M, Tanaka S, Oue N, Yasui W . Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun. 2003; 311(4):809-14. DOI: 10.1016/j.bbrc.2003.10.077. View

19.

Savage S, Hou L, Lissowska J, Chow W, Zatonski W, Chanock S . Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev. 2006; 15(3):589-91. DOI: 10.1158/1055-9965.EPI-05-0887. View

20.

Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M . The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther. 2003; 18(2):245-52. DOI: 10.1046/j.1365-2036.2003.01669.x. View